In the News

US Regulatory Roundup, March 2022: QMSR Draft Highlights; More Headaches For Philips; Essure Wreaks Havoc, Medtech Insight

Wednesday, April 6, 2022

In a regulatory roundup of Medtech Insight’s most-read articles in March, pieces analyzing the US Food and Drug Administration’s (FDA’s) proposed Quality Management System Regulation (QMSR) were among the top 10. In the No. 7 slot was an interview feature with partner Dennis Gucciardo on the “four steps device makers can take now to make sure they’re not caught behind the 8 ball once the proposed QMSR is finalized.”

Read the full Medtech Insight article >>